Investing.com — フランスの製薬大手Sanofi SA (EPA: SASY )は水曜日、米国上場のバイオテク企業Vigil Neuroscience Inc (NASDAQ: VIGL ...

Vigil Neuroscience (VIGL)の株価は今日はいくらですか？ Vigil Neuroscienceの株価は本日7.89です どの株式取引所でVigil Neuroscience株は取引されていますか？ Vigil Neuroscienceは、ナスダック・ストックエクスチェンジ株式取引所に上場され、取引されています。 Vigil ...

French pharma Sanofi has acquired the U.S.-based biotech firm Vigil Neuroscience for $470 million, aiming to bolster its ...

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Vigil Neuroscience (VIGL) and Sanofi (SNY) announced that it has entered into a definitive merger agreement pursuant to which ...

Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the ...

Part of the deal also includes an additional $2 cash payment per share upon the first commercial sale of Vigil’s Alzheimer’s ...

Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) ...

Key Takeaways Vigil Neuroscience shares more than tripled Thursday after the company reached a deal to be acquired by ...

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

While Vigil stock rocketed upward on the news, Sanofi shares dipped slightly in midday trading, reflecting investor caution ...

On May 22, 2025, Vigil Neuroscience, Inc., a biotechnology company with a market capitalization of $368 million and currently trading near its 52-week high of $7.95, conducted its 2025 Annual ...